Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1958 1
1959 1
1961 3
1962 2
1963 5
1964 6
1965 5
1966 4
1967 4
1968 1
1969 3
1970 2
1973 1
1974 1
1975 1
1976 1
1977 4
1978 8
1979 5
1980 6
1981 9
1982 14
1983 6
1984 6
1985 9
1986 5
1987 7
1988 7
1989 8
1990 13
1991 15
1992 12
1993 21
1994 15
1995 10
1996 18
1997 25
1998 15
1999 23
2000 19
2001 26
2002 20
2003 44
2004 46
2005 69
2006 49
2007 53
2008 70
2009 75
2010 80
2011 77
2012 101
2013 105
2014 97
2015 90
2016 102
2017 100
2018 125
2019 122
2020 115
2021 144
2022 168
2023 118
2024 114
2025 125

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,275 results

Results by year

Filters applied: . Clear all
Page 1
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.
Martin T, Usmani SZ, Berdeja JG, Agha M, Cohen AD, Hari P, Avigan D, Deol A, Htut M, Lesokhin A, Munshi NC, O'Donnell E, Stewart AK, Schecter JM, Goldberg JD, Jackson CC, Yeh TM, Banerjee A, Allred A, Zudaire E, Deraedt W, Olyslager Y, Zhou C, Pacaud L, Madduri D, Jakubowiak A, Lin Y, Jagannath S. Martin T, et al. Among authors: yeh tm. J Clin Oncol. 2023 Feb 20;41(6):1265-1274. doi: 10.1200/JCO.22.00842. Epub 2022 Jun 4. J Clin Oncol. 2023. PMID: 35658469 Free PMC article.
Antibiotic resistance in Enterobacter hormaechei.
Yeh TK, Lin HJ, Liu PY, Wang JH, Hsueh PR. Yeh TK, et al. Int J Antimicrob Agents. 2022 Oct;60(4):106650. doi: 10.1016/j.ijantimicag.2022.106650. Epub 2022 Aug 4. Int J Antimicrob Agents. 2022. PMID: 35934231 Review.
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.
San-Miguel J, Dhakal B, Yong K, Spencer A, Anguille S, Mateos MV, Fernández de Larrea C, Martínez-López J, Moreau P, Touzeau C, Leleu X, Avivi I, Cavo M, Ishida T, Kim SJ, Roeloffzen W, van de Donk NWCJ, Dytfeld D, Sidana S, Costa LJ, Oriol A, Popat R, Khan AM, Cohen YC, Ho PJ, Griffin J, Lendvai N, Lonardi C, Slaughter A, Schecter JM, Jackson CC, Connors K, Li K, Zudaire E, Chen D, Gilbert J, Yeh TM, Nagle S, Florendo E, Pacaud L, Patel N, Harrison SJ, Einsele H. San-Miguel J, et al. Among authors: yeh tm. N Engl J Med. 2023 Jul 27;389(4):335-347. doi: 10.1056/NEJMoa2303379. Epub 2023 Jun 5. N Engl J Med. 2023. PMID: 37272512 Clinical Trial.
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Jabbour E, Kantarjian HM, Aldoss I, Montesinos P, Leonard JT, Gómez-Almaguer D, Baer MR, Gambacorti-Passerini C, McCloskey J, Minami Y, Papayannidis C, Rocha V, Rousselot P, Vachhani P, Wang ES, Wang B, Hennessy M, Vorog A, Patel N, Yeh T, Ribera JM. Jabbour E, et al. Among authors: yeh t. JAMA. 2024 Jun 4;331(21):1814-1823. doi: 10.1001/jama.2024.4783. JAMA. 2024. PMID: 38722621 Free PMC article. Clinical Trial.
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH; CLASSIC trial investigators. Bang YJ, et al. Among authors: yeh ts. Lancet. 2012 Jan 28;379(9813):315-21. doi: 10.1016/S0140-6736(11)61873-4. Epub 2012 Jan 7. Lancet. 2012. PMID: 22226517 Clinical Trial.
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Kang YK, Terashima M, Kim YW, Boku N, Chung HC, Chen JS, Ji J, Yeh TS, Chen LT, Ryu MH, Kim JG, Omori T, Rha SY, Kim TY, Ryu KW, Sakuramoto S, Nishida Y, Fukushima N, Yamada T, Bai LY, Hirashima Y, Hagihara S, Nakada T, Sasako M. Kang YK, et al. Among authors: yeh ts. Lancet Gastroenterol Hepatol. 2024 Aug;9(8):705-717. doi: 10.1016/S2468-1253(24)00156-0. Epub 2024 Jun 18. Lancet Gastroenterol Hepatol. 2024. PMID: 38906161 Clinical Trial.
Multi-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation.
Liao G, Nakayama T, Zhu B, Lee IT, Yeung J, Yeo YY, Chang Y, Wang C, Liao SC, Nkosi D, Renteria A, Bravo DT, Overdevest JB, Yan CH, Zarabanda D, Gall PA, Dholakia SS, Borchard NA, Yang A, Kim D, Patel ZM, Hwang PH, Wagh D, Coller J, Phillips KM, Chang MT, Lechner M, Li Z, Yeh TH, Nolan G, Longhi MS, Boussiotis V, Barouch DH, Ma Q, Nayak JV, Jiang S. Liao G, et al. Among authors: yeh th. Immunity. 2025 Oct 14;58(10):2593-2608.e6. doi: 10.1016/j.immuni.2025.08.009. Epub 2025 Sep 12. Immunity. 2025. PMID: 40945518 Free article.
Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis.
Liang CS, Li DJ, Yang FC, Tseng PT, Carvalho AF, Stubbs B, Thompson T, Mueller C, Shin JI, Radua J, Stewart R, Rajji TK, Tu YK, Chen TY, Yeh TC, Tsai CK, Yu CL, Pan CC, Chu CS. Liang CS, et al. Among authors: yeh tc. Lancet Healthy Longev. 2021 Aug;2(8):e479-e488. doi: 10.1016/S2666-7568(21)00140-9. Epub 2021 Jul 21. Lancet Healthy Longev. 2021. PMID: 36097997 Free article.
2,275 results